BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasrolahi A, Safari F, Farhoudi M, Khosravi A, Farajdokht F, Bastaminejad S, Sandoghchian Shotorbani S, Mahmoudi J. Immune system and new avenues in Parkinson’s disease research and treatment. Reviews in the Neurosciences 2019;30:709-27. [DOI: 10.1515/revneuro-2018-0105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Khairnar RC, Parihar N, Prabhavalkar KS, Bhatt LK. Emerging targets signaling for inflammation in Parkinson's disease drug discovery. Metab Brain Dis 2022. [PMID: 35536461 DOI: 10.1007/s11011-022-00999-2] [Reference Citation Analysis]
2 Contaldi E, Magistrelli L, Comi C. T Lymphocytes in Parkinson's Disease. J Parkinsons Dis 2022. [PMID: 35253782 DOI: 10.3233/JPD-223152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mehmood A, Ali W, Din ZU, Song S, Sohail M, Shah W, Guo J, Guo RY, Ilahi I, Shah S, Al-Shaebi F, Zeb L, Asiamah EA, Al-Dhamin Z, Bilal H, Li B. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease. Brain Behav 2021. [PMID: 34291612 DOI: 10.1002/brb3.2280] [Reference Citation Analysis]
4 Zhang X, Wang J, Gao JZ, Zhang XN, Dou KX, Shi WD, Xie AM. P2X4 receptor participates in autophagy regulation in Parkinson's disease. Neural Regen Res 2021;16:2505-11. [PMID: 33907041 DOI: 10.4103/1673-5374.313053] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Wang S, Han QW, Zhou TT, Zhang CL, Zhu CG, Zhou X, Chen NH, Yuan YH, Shi JG. A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules. Int Immunopharmacol 2021;91:107269. [PMID: 33340781 DOI: 10.1016/j.intimp.2020.107269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lei K, Zhang L, He Y, Sun H, Tong W, Xu Y, Jin L. Immune-associated biomarkers for early diagnosis of Parkinson's disease based on hematological lncRNA-mRNA co-expression. Biosci Rep 2020:BSR20202921. [PMID: 33245101 DOI: 10.1042/BSR20202921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Shomali N, Mahmoodpoor A, Abbas Abad AN, Marofi F, Akbari M, Xu H, Sandoghchian Shotorbani S. The Relationship between Extracellular/intracellular microRNAs and TLRs May Be Used as a Diagnostic and Therapeutic Approach in Sepsis. Immunol Invest 2020;:1-16. [PMID: 33054447 DOI: 10.1080/08820139.2020.1817067] [Reference Citation Analysis]
9 Zhang X, Xue L, Sun X, Jin J, Bai X, Xie A. Association of IL-16 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neuroscience Letters 2020;724:134877. [DOI: 10.1016/j.neulet.2020.134877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Safari F, Hatam G, Behbahani AB, Rezaei V, Barekati-Mowahed M, Petramfar P, Khademi F. CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease. Cell Mol Neurobiol 2020;40:477-93. [PMID: 31773362 DOI: 10.1007/s10571-019-00761-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
11 Shomali N, Baradaran B, Deljavanghodrati M, Akbari M, Hemmatzadeh M, Mohammadi H, Jang Y, Xu H, Sandoghchian Shotorbani S. A new insight into thymosin β4, a promising therapeutic approach for neurodegenerative disorders. J Cell Physiol 2020;235:3270-9. [PMID: 31612500 DOI: 10.1002/jcp.29293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Calderón-garcidueñas L, Reynoso-robles R, González-maciel A. Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: The culprit of Alzheimer and Parkinson's diseases. Environmental Research 2019;176:108574. [DOI: 10.1016/j.envres.2019.108574] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]